|
COMMERCE BUSINESS DAILY ISSUE OF APRIL 14,1995 PSA#1325DHHS/PHS/FDA/OCGM/Division of Contracts and Procurement
Management/Contracts Operations Branch, HFA-512, 5600 Fishers Lane,
Park Building, Room 3-32, Rockville, Maryland 20857 A -- EVALUATION OF INFLUENZA VIRUS VACCINES IN HIGH RISK INFECTION
CATEGORIES SOL 223-95-1102 DUE 053095 POC Paul Scarborough, Contracting
Officer (301) 443-4420, The FDA has a need for the continuation of a
program for the study of influenza virus vaccination in high risk
individuals, currently being performed at Hackensack Medical Center.
Institutions responding to this RFP must have an ongoing program of
influenza virus vaccine evaluation and expertise in patient care and
treatment with the capability to provide a minimum of 250 patients
considered at high risk to the complications of respiratory infections.
(0102) Loren Data Corp. http://www.ld.com (SYN# 0006 19950413\A-0006.SOL)
A - Research and Development Index Page
|
|